A combination of gonadotropin-releasing hormone analog and human menopausal gonadotropins for ovulation induction in premature ovarian failure.
A combination of gonadotropin-releasing hormone agonist and human menopausal gonadotropins was used for ovulation induction in a patient with premature ovarian failure. A paradoxical suppression of any ovarian response was noted despite increasing doses of human menopausal gonadotropins.
Letterie
G
G
Department of Obstetrics and Gynecology, Tripler Army Medical Center, Honolulu, Hawaii.
Miyazawa
K
K
D000328:Adult; D003692:Delayed-Action Preparations; D004359:Drug Therapy, Combination; D004958:Estradiol / Q000097:blood; D005260:Female; D005640:Follicle Stimulating Hormone / Q000097:blood; D007987:Gonadotropin-Releasing Hormone / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006801:Humans; D007247:Infertility, Female / Q000209:etiology / Q000628:therapy*; D007986:Luteinizing Hormone / Q000097:blood; D008596:Menotropins / Q000627:therapeutic use*; D010062:Ovulation Induction / Q000379:methods*; D016649:Primary Ovarian Insufficiency / Q000150:complications* / Q000503:physiopathology; D017329:Triptorelin Pamoate / Q000031:analogs & derivatives*
D003692:Delayed-Action Preparations; D017329:Triptorelin Pamoate; D007987:Gonadotropin-Releasing Hormone; D004958:Estradiol; C019176:Tryptal; D008596:Menotropins; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone